Literature DB >> 16750368

A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy.

Kristin J Krosschell1, Jo Anne Maczulski, Thomas O Crawford, Charles Scott, Kathryn J Swoboda.   

Abstract

The Hammersmith functional motor scale for children with spinal muscular atrophy was modified to establish a standard measure of functional ability in children with non-ambulant spinal muscular atrophy types 2 and 3 in a longitudinal multi-center clinical trial. This study assessed the intra- and interrater reliability and the test-retest stability of a modified version of the scale. Both intra- and interrater reliability were established. Results indicate that the scale is reliable and stable over a 6 month period. Reliability was maintained when patient sample criteria were expanded to include children younger than 30 months and children with popliteal angles greater than 20 degrees . These data establish the modified Hammersmith functional motor scale for children with spinal muscular atrophy as a reliable instrument for use in multi-center treatment trials in non-ambulant spinal muscular atrophy children. Our data provides additional support for the use of original scale items in terms of ease of administration, usefulness and reliability, while incorporating modifications to optimize its use in a multi-center clinical research setting.

Entities:  

Mesh:

Year:  2006        PMID: 16750368      PMCID: PMC3260054          DOI: 10.1016/j.nmd.2006.03.015

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  34 in total

1.  High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.

Authors:  Anne M Connolly; Jeanine Schierbecker; Renee Renna; Julaine Florence
Journal:  Neuromuscul Disord       Date:  2002-12       Impact factor: 4.296

2.  The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation.

Authors:  Marion Main; Harvey Kairon; Eugenio Mercuri; Francesco Muntoni
Journal:  Eur J Paediatr Neurol       Date:  2003       Impact factor: 3.140

Review 3.  Review of the reliability and validity of myometry with children.

Authors:  Colleen Sloan
Journal:  Phys Occup Ther Pediatr       Date:  2002       Impact factor: 2.360

Review 4.  Intraclass correlations: uses in assessing rater reliability.

Authors:  P E Shrout; J L Fleiss
Journal:  Psychol Bull       Date:  1979-03       Impact factor: 17.737

Review 5.  Concerns about the design of clinical trials for spinal muscular atrophy.

Authors:  Thomas O Crawford
Journal:  Neuromuscul Disord       Date:  2004-09       Impact factor: 4.296

6.  Outcome measures for pediatric spinal muscular atrophy.

Authors:  Susan T Iannaccone
Journal:  Arch Neurol       Date:  2002-09

7.  Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy.

Authors:  O M Scott; S A Hyde; C Goddard; V Dubowitz
Journal:  Muscle Nerve       Date:  1982-04       Impact factor: 3.217

8.  Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study.

Authors:  Luciano Merlini; Alessandra Solari; Giuseppe Vita; Enrico Bertini; Carlo Minetti; Tiziana Mongini; Elena Mazzoni; Corrado Angelini; Lucia Morandi
Journal:  J Child Neurol       Date:  2003-08       Impact factor: 1.987

9.  Motor function-muscle strength relationship in spinal muscular atrophy.

Authors:  Luciano Merlini; Enrico Bertini; Carlo Minetti; Tiziana Mongini; Lucia Morandi; Corrado Angelini; Giuseppe Vita
Journal:  Muscle Nerve       Date:  2004-04       Impact factor: 3.217

10.  Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy.

Authors:  Catia Andreassi; Carla Angelozzi; Francesco D Tiziano; Tiziana Vitali; Eleonora De Vincenzi; Alma Boninsegna; Marcello Villanova; Enrico Bertini; Antonella Pini; Giovanni Neri; Christina Brahe
Journal:  Eur J Hum Genet       Date:  2004-01       Impact factor: 4.246

View more
  24 in total

1.  Spinal muscular atrophy: advances in research and consensus on care of patients.

Authors:  Ching H Wang; Mitchell R Lunn
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

2.  Rasch analysis of clinical outcome measures in spinal muscular atrophy.

Authors:  Stefan J Cano; Anna Mayhew; Allan M Glanzman; Kristin J Krosschell; Kathryn J Swoboda; Marion Main; Birgit F Steffensen; Carole Bérard; Françoise Girardot; Christine A M Payan; Eugenio Mercuri; Elena Mazzone; Bakri Elsheikh; Julaine Florence; Linda S Hynan; Susan T Iannaccone; Leslie L Nelson; Shree Pandya; Michael Rose; Charles Scott; Reza Sadjadi; Mackensie A Yore; Cynthia Joyce; John T Kissel
Journal:  Muscle Nerve       Date:  2013-07-26       Impact factor: 3.217

3.  English cross-cultural translation and validation of the neuromuscular score: a system for motor function classification in patients with neuromuscular diseases.

Authors:  Carole Vuillerot; Katherine G Meilleur; Minal Jain; Melissa Waite; Tianxia Wu; Melody Linton; Jahannaz Datsgir; Sandra Donkervoort; Meganne E Leach; Anne Rutkowski; Pascal Rippert; Christine Payan; Jean Iwaz; Dalil Hamroun; Carole Bérard; Isabelle Poirot; Carsten G Bönnemann
Journal:  Arch Phys Med Rehabil       Date:  2014-05-24       Impact factor: 3.966

4.  Compound muscle action potential and motor function in children with spinal muscular atrophy.

Authors:  Aga Lewelt; Kristin J Krosschell; Charles Scott; Ai Sakonju; John T Kissel; Thomas O Crawford; Gyula Acsadi; Guy D'anjou; Bakri Elsheikh; Sandra P Reyna; Mary K Schroth; Jo Anne Maczulski; Gregory J Stoddard; Elie Elovic; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2010-11       Impact factor: 3.217

5.  Reliability and validity of the TIMPSI for infants with spinal muscular atrophy type I.

Authors:  Kristin J Krosschell; Jo Anne Maczulski; Charles Scott; Wendy King; Jill T Hartman; Laura E Case; Donata Viazzo-Trussell; Janine Wood; Carolyn A Roman; Eva Hecker; Marianne Meffert; Maude Léveillé; Krista Kienitz; Kathryn J Swoboda
Journal:  Pediatr Phys Ther       Date:  2013       Impact factor: 3.049

6.  Reliability of the Modified Hammersmith Functional Motor Scale in young children with spinal muscular atrophy.

Authors:  Kristin J Krosschell; Charles B Scott; Jo Anne Maczulski; Aga J Lewelt; Sandra P Reyna; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2011-06-22       Impact factor: 3.217

7.  Resistance strength training exercise in children with spinal muscular atrophy.

Authors:  Aga Lewelt; Kristin J Krosschell; Gregory J Stoddard; Cindy Weng; Mei Xue; Robin L Marcus; Eduard Gappmaier; Louis Viollet; Barbara A Johnson; Andrea T White; Donata Viazzo-Trussell; Philippe Lopes; Robert H Lane; John C Carey; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2015-10       Impact factor: 3.217

Review 8.  Perspectives on clinical trials in spinal muscular atrophy.

Authors:  Kathryn J Swoboda; John T Kissel; Thomas O Crawford; Mark B Bromberg; Gyula Acsadi; Guy D'Anjou; Kristin J Krosschell; Sandra P Reyna; Mary K Schroth; Charles B Scott; Louise R Simard
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

9.  SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy.

Authors:  Kathryn J Swoboda; Charles B Scott; Thomas O Crawford; Louise R Simard; Sandra P Reyna; Kristin J Krosschell; Gyula Acsadi; Bakri Elsheik; Mary K Schroth; Guy D'Anjou; Bernard LaSalle; Thomas W Prior; Susan L Sorenson; Jo Anne Maczulski; Mark B Bromberg; Gary M Chan; John T Kissel
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

10.  Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy.

Authors:  Wendy K M Liew; Peter B Kang
Journal:  Ther Adv Neurol Disord       Date:  2013-05       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.